Patient P-02531

Synthetic patientMETA-24 · Day 125 · 65–74 · F · baseline S09Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Improving

GI state

Deteriorating

Inflammatory state

Favorable

Nutritional resilience

Declining

Discontinuation risk

28%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S09
Day 10 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 10.

Primary contributors, last 14 days

Nutritional resilience-15
Toxicity-8
GI instability+7
Treatment adherence+5

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

71 min

stable · -0.6 vs previous 14 d

Sleep duration

Wearable

7.2 h

improving · +0.4 vs previous 14 d

Energy level

Daily log

6/10

stable · +0.1 vs previous 14 d

Steps

Wearable

7,029

stable · -106 vs previous 14 d

GI burden

Companion

32.4/100

stable · +0.1 vs previous 14 d

Adherence

Companion

95 %

stable · +1.4 vs previous 14 d

Sleep quality

Wearable

58.9/100

improving · +6.9 vs previous 14 d

Glucose, CGM daily mean

CGM

136 mg/dL

stable · -5.0 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 61 from the failing basin, 27 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -4.2 next day on high-intake days · n 22

Would not help

Keep alcohol low
GI +3.2 next day on high-intake days · n 21

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-4.2supporter · 95%
Alcohol
+3.2detractor · 95%
Dietary fat load
-1.3no signal · 34%
Simple carbohydrates
+1.1no signal · 29%
Histamine load
+0.9no signal · 25%
Caffeine
-0.3no signal · 15%
Ultra-processed food
-0.3no signal · 15%
Insoluble fibre
0no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 4.6 · butyrate capacity 74/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 54 ms
Sleep: 7.7 h
Steps: 5,739
Resting HR: 66 bpm

Daily log: GI score 32, nutritional resilience 53, adherence 95.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02285	32%	S14	AD-05	no change	39
P-02093	31%	S05	AD-05	no change	40
P-02483	44%	S06	BR-03	no change	64
P-02280	38%	S07	BR-03	no change	50
P-02267	37%	S09	BR-03	no change	45
P-02087	36%	S01	BR-03	no change	40
P-02638	32%	S01	BR-03	improved	41
P-02354	35%	S01	CR-01	improved	78
P-02491	58%	S09	DT-01	no change	65
P-02462	44%	S12	DT-01	improved	65
P-02274	40%	S15	DT-01	improved	50
P-02518	40%	S17	DT-01	improved	68